期刊文献+

猪圆环病毒2型ORF2基因的定点突变及其真核表达载体的构建 被引量:2

Site-directed Mutagenesis of PCV2 ORF2 Gene Based on Overlap Extension PCR and Construction of Eukaryotic Expression Vector
在线阅读 下载PDF
导出
摘要 根据GenBank发表的猪圆环病毒2型(PCV2)ORF2基因序列设计并合成引物,采用重叠延伸PCR(splice overlap extension PCR,SOE-PCR)定点诱变技术对ORF2基因进行定点突变。DNA测序结果表明,ORF2基因片段的372—378 bp处的碱基由TCTAGAT突变为ATTGGAT,从而破坏酶切位点XbaⅠ,成功获得ORF2的突变基因片段。进而将其连接到腺病毒真核表达载体pAD5-Blue中,成功构建真核表达载体,并获得PCV2的Cap蛋白表达产物,为PCV2新型疫苗研究奠定了重要基础。 Based on the ORF2 sequences of PCV2 available in GenBank,two pairs of primers were designed and site-directed mutagenesis method based on overlap extension PCR was used to introduce mutations in the ORF2 fragment.DNA sequencing showed that TCTAGAT of 372 to 378 bp sites had been changed into TATAACT from mutagenesis,the endonuclease sites XbaⅠwas destroyed,site-directed mutagenesis was successfully implemented.Eukaryotic expression vector(pAD5-Blue) was constructed and expressed biological activity protein of Cap.It laid the foundation for further study and played a great role for the PCV2 subunit vaccine research.
出处 《中国畜牧兽医》 CAS 北大核心 2011年第2期99-103,共5页 China Animal Husbandry & Veterinary Medicine
关键词 猪圆环病毒2型 ORF2基因 重叠延伸PCR pAD5-Blue CAP蛋白 PCV2 ORF2 gene overlap extension PCR pAD5-Blue protein of Cap
  • 相关文献

参考文献9

  • 1王忠田,杨汉春,郭鑫.猪圆环病毒研究进展[J].中国兽医杂志,2004,40(3):33-35. 被引量:22
  • 2王福喜,魏凤明,张英俊,徐斌龙.猪圆环病毒病[J].吉林畜牧兽医,2010,31(2):19-20. 被引量:1
  • 3帅勇,胡兴旺,易朵,王成,赵晓蒙,周畅.重叠延伸PCR法构建小鼠Sumf1基因的定点突变真核表达载体[J].生命科学研究,2009,13(5):430-436. 被引量:8
  • 4李和刚,傅田,靳二辉,操继跃,李奎,肖邦,杨述林.猪IκBα基因定点突变中两种方法的应用[J].中国畜牧兽医,2009,36(1):38-40. 被引量:2
  • 5黄培堂 俞炜源 陈添弥译 迪芬巴赫CW 德维克斯勒GS.PCR技术实验指南[M].北京:科学出版社,1999.206-17.
  • 6Adam E, Nasz I. Significance of recombinant adenovirus in experimental gene therapy[J]. Orv Hetil, 1995, 136(15) :755-761.
  • 7Blanehard P, Mahe D, Cariolet R, et al. Protection of swine against posting-weaning multisystemie wasting syndrome(PMWS) by porcine circovirus type 2 (PCV2) proteins[J]. Vaccine, 2003, 21(31) :4565-4575.
  • 8Mauro P M, Gregory A M, Marvin J G. pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs[J]. BioTechniques, 2001,31 (5) : 1050 - 1056.
  • 9Mayr G A, Donnell V O, Chinsangaram J, et al. Immune responses and protection against foot and mouth disease virus(FMDV) challenge in swine vaccinated with adenovirus FMDV constructs. Vaccine,2001,19(15-16) :2152-2162.

二级参考文献24

  • 1罗师平,冷希岗.基于PCR的体外诱变技术[J].国外医学(生物医学工程分册),2005,28(3):188-192. 被引量:25
  • 2朱大兴,周清华,王艳萍,车国卫,唐小军,朱文,陈小禾,孙芝琳.利用Pyrobest DNA聚合酶一步法进行大片段基因的定点突变[J].生物技术通讯,2007,18(4):590-593. 被引量:4
  • 3Auchincloss H, D H Sachs. Xenogeneic transplantation[J]. Annu Rev Immunol, 1998, 16:433-470.
  • 4Brasier A R. The NF-kappaB regulatory network[J]. Cardiovasc Toxicol,2006, 6(2):111-130.
  • 5Hayden M S, West A P, Ghosh S. NF kappaB and the immune response[J].Oncogene, 2006, 25(51):6758-6780.
  • 6Heckman K L, Pease L R. Gene splicing and mutagenesis by PCR-driven overlap extension[J].Nat Protoc, 2007,2 (4) : 924 - 932.
  • 7Patrick V, Marie-Paule M, Vincent B, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation[J].Trends Biochem Sci, 2005,30 ( 1 ) : 43-52.
  • 8Yingfeng A,Jianfei J, Wenfang W, et al. A rapid and efficient method for multiple-site mutagenesis with a modified overlap extension PCR [J]. Appl Microbiol Bioteehnol, 2005,68:774-778.
  • 9MCPHERSON L A, WEIGEL R J. AP-2 α and AP-2 γ: a comparison of binding site specificity and transactivation of the estrogen receptor promoter and single site promoter constructs[J]. Nucleic Acids Research, 1999, 27(20): 4040- 4049.
  • 10MITCHELL P J, WANG C, TJIAN R. Positive and negative regulation of transcription in vitro: enhancer binding protein AP-2 is inhibited by SV 40 T antigen[J]. Cell, 1987, 50: 847-861.

共引文献35

同被引文献47

  • 1宋云峰,肖少波,金梅林,张松林,陈焕春.猪2型圆环病毒核酸疫苗免疫效应研究[J].畜牧兽医学报,2005,36(10):1049-1054. 被引量:13
  • 2刘永平,王方海,苏志坚,李广宏,庞义.昆虫杆状病毒表达载体系统的研究及应用[J].昆虫知识,2006,43(1):1-5. 被引量:22
  • 3Allan G M,Wllis J A. Porcine cireoviruses: A review[J].J Vet Diagn Invest, 2000,12 : 3 -4.
  • 4Claae C. A review of porcine circovirus 2 associated syndromes and diseases[J].Vet J,2005,169(3):326-336.
  • 5Ellis J, Krakowka S, Lairmore M, et al. Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglet[J]. Vet Diagn Invest, 1999,11 ( 1 ) : 3 -14.
  • 6Fenaux M,Opriessing T, Halbur P G,et al. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs[J]. J Virol,2003,77(2) :11232-11243.
  • 7Fenaux M, Opriessning T, Halbur P G, et al. Two amino acid mutations in the capsid protein of type 2 porcine circovrius (PCV2) enhanced PCV2 replication in vitro and attenuated the virus invivo[J]. J Virol,2004,78(24):13440-13446.
  • 8KamstrupS,Barfoed A M,Frimann T H,et al. Immunisationa gainst PCV2 structural protein by DNA vaccination of mice[J]. Vaccine,2004,22: 1358- 1361.
  • 9Kim Y,Kim J, Kang K, et al. Characterization of the recombi- nant proteins of porcine eireovirus type 2 field isolate expressed in the baculovirus system[J].J Vet Sci, 2002,3 ( 1 ) : 19 - 23.
  • 10Maeda S,Kawai T, Obinata M, et al. Production of human a-in terferon in silkworm using a baculovirus vector[J]. Nature, 1985,315:592-594.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部